-
AbbVie Inc. (NYSE:ABBV) Q4 2024 Earnings Call Transcript
01 Feb 2025 13:13 GMT
… programs. These advancements include recent approvals for Skyrizi in UC, … , we met with the FDA late last year regarding our … And we see similar market shares in those countries as well … Follow Abbvie Inc. (NYSE:ABBV) Follow Abbvie Inc. (NYSE:ABBV) We may …
-
Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
01 Feb 2025 11:36 GMT
… investing in stocks is an excellent strategy. Buying shares of the … options: AbbVie (NYSE: ABBV) and Novo Nordisk (NYSE: NVO). AbbVie … company to earn brand-new approvals, be it thanks to … Food and Drug Administration (FDA) approved just the first MASH …
-
FDA approves pharma giant's 'first-in-class' non-opioid pain medication
01 Feb 2025 03:45 GMT
… ," according to the FDA.
Vertex Pharmaceuticals' … another treatment option," FDA Center for Drug Evaluation … WEIGHT-LOSS MEDICATION, GETS FDA APPROVAL FOR USE AS HEART DISEASE … FDA approval, Vertex saw gains in its stock price, with its shares …
-
Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds
31 Jan 2025 19:55 GMT
… brand name Journavx.
“Today’s approval is an important public health … Curay, acting director of the FDA’s Center for Drug Evaluation … Vertex about 25 years ago.
FDA approval of Journavx is based on … test.
Zelis CEO Amanda Eisel shares her perspective on how the …
-
Vertex bags FDA okay for its non-opioid pain drug
31 Jan 2025 18:35 GMT
Vertex Pharma has secured FDA approval for its non-opioid pain … prolonged period.
Journavx's approval is an "important public … for severe chronic pain.
Its approval is based on positive results … a sell-off in its shares.
Along with LSR, Vertex is …
-
Vertex Pharmaceuticals Shares Are Up Today: What's Going On?
31 Jan 2025 17:09 GMT
… To Know: The company secured FDA approval for JOURNAVX, a non-opioid … . This marks the first approval of a new class of … traditional opioid treatments. The approval may signal regulatory confidence in … .
VRTX Price Action: Vertex shares were up 4.96% at …
-
Fierce Pharma Asia—Takeda's next CEO; Enhertu's novel FDA nod; East Asian American C-suite execs
31 Jan 2025 16:19 GMT
… axes failed epilepsy asset after FDA weighs in on data package … case in Dravet syndrome, the FDA disagreed.
3. Takeda bids adieu … Enhertu has gained another landmark FDA approval that allows the antibody-drug … IPO as Ascentage makes $126M Nasdaq debut
-
Markets News, January 31, 2025: Stocks Slip as White House Says Tariffs Coming Saturday; Major Indexes Post Gains for January
31 Jan 2025 16:13 GMT
… of gains for the Nasdaq, while the Dow and S&P … tech, sending shares of Nvidia and other AI stocks into a tailspin … Opioid Painkiller Gets FDA Approval
10 hr 27 min ago
Shares of Vertex …
Since early December, Atlassian shares have consolidated in a pennant …
-
Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday
31 Jan 2025 15:51 GMT
U.S. stocks were higher, with the Nasdaq Composite gaining more than … Here are some other big stocks recording gains in today… .
Viavi Solutions Inc. VIAV shares jumped 26% to $12.58 … the company announced it secured FDA approval for JOURNAVX. Also, the …
-
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval
31 Jan 2025 15:19 GMT
… 15.50 per 50mg pill.
Shares of Vertex Pharmaceuticals (VRTX) … the Food and Drug Administration (FDA) has approved Journavx, a … Pain Steering Committee, called the approval "an incredible day … The news sent Vertex Pharmaceuticals shares, which had been up …